Science Explorer Back to mapMap
Discussion
Company · Derio · Spain

Oncomatryx (Spain)

oncomatryx.comROR OpenAlex
Research works
4
▲ 74% vs 2018-21
Citations
36
8.8 per fractional work
Top-10% rate
9.3%
all institutions 10.0%
Open access
48%
world 40%
International
47%
world 18%
Oncomatryx (Spain)

Not ranked overall: Oncomatryx (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Oncomatryx (Spain) work in?

In all years, 51% of research at Oncomatryx (Spain) is in Health Sciences, 44% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (41%), Engineering (5%). It does 1.3× the world's share of Life Sciences.

Health Sciences: 2 fractional works · 51.2% of its workMedicine: 2 fractional works · 51.2% of its workLife Sciences: 2 fractional works · 43.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 41.5% of its workImmunology and Microbiology: 0 fractional works · 2.4% of its workPhysical Sciences: 0 fractional works · 4.9% of its workEngineering: 0 fractional works · 4.9% of its workALL ITS WORKOncomatryx(Spain)4fractional works, all years
Life Sciences44%Physical Sciences5%Health Sciences51%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Medicine251.2%
    1. Biochemistry, Genetics and Molecular Biology241.5%
    2. Immunology and Microbiology02.4%
    1. Engineering04.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at Oncomatryx (Spain)?

Ranked on the quality score, Myriam Fabre, Laureano Simón and Isabel Egaña lead among researchers whose main affiliation is Oncomatryx (Spain).

  1. 1 Myriam Fabre Spain · #1,766,373 worldwide 1.8k citations · 64 works
  2. 2 Laureano Simón Spain · #3,034,729 worldwide 930 citations · 69 works
  3. 3 Isabel Egaña Spain · #3,794,728 worldwide 199 citations · 18 works
All ranked researchers at Oncomatryx (Spain)

What are the most cited papers from Oncomatryx (Spain)?

The most cited paper from Oncomatryx (Spain) is "Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer" (Carmen García-Pravia, José A. Galván, Natalia Gutiérrez-Corral et al., 2013), with 97 citations. Next come "Collagen, type XI, alpha 1: An accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies" (27) and "In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma" (20).

Most cited papers
#PaperReleasedCitations
1 Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer Carmen García-Pravia, José A. Galván, Natalia Gutiérrez-Corral et al. · PLoS ONE Open access 23 Oct 2013 97
2 Collagen, type XI, alpha 1: An accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies Javier Freire, Saioa Domínguez-Hormaetxe, Saray Pereda et al. · Pathology - Research and Practice 8 Aug 2014 27
3 In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma Montserrat Pérez-Salvia et al. · Haematologica Open access 7 Jun 2018 20
4 Targeting carcinoma‐associated mesothelial cells with antibody–drug conjugates in ovarian carcinomatosis Lucía Pascual‐Antón, Pilar Sandoval, Guadalupe Tirma Gónzalez-Mateo et al. · The Journal of Pathology Open access 9 Aug 2023 16
5 Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles as a Diagnostic Tool for Neoplastic Processes Begoña Otero‐Alén, Lara Sofía Estévez-Pérez, María Otero-Alén et al. · International Journal of Molecular Sciences Open access 10 Feb 2023 7
All 10 most cited papers, with filters and sorting

Which research topics does Oncomatryx (Spain) publish most on?

By volume in 2022-now: Cancer Cells and Metastasis, Inflammatory mediators and NSAID effects, Ubiquitin and proteasome pathways and Nanoplatforms for cancer theranostics.

Cancer Cells and Metasta…0Cancer Cells and Metastasis: 0 fractional worksInflammatory mediators a…0Inflammatory mediators and NSAID effects: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksNanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksNitric Oxide and Endothe…0Nitric Oxide and Endothelin Effects: 0 fractional worksEstrogen and related hor…0Estrogen and related hormone effects: 0 fractional worksMicroRNA in disease regulation: 0 fractional worksCircular RNAs in diseases: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional works
OncologyPharmacologyMolecular BiologyBiomedical Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Cells and Metastasis Oncology 0 works
  2. 2 Inflammatory mediators and NSAID effects Pharmacology 0 works
  3. 3 Ubiquitin and proteasome pathways Molecular Biology 0 works
  4. 4 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  5. 5 Peptidase Inhibition and Analysis Oncology 0 works
  6. 6 Nitric Oxide and Endothelin Effects Physiology 0 works
  7. 7 Estrogen and related hormone effects Genetics 0 works
  8. 8 MicroRNA in disease regulation Cancer Research 0 works
  9. 9 Circular RNAs in diseases Molecular Biology 0 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.6%not open52.4%

World: 40% of research is openly available.

with international co-authors46.7%domestic only53.3%

World: 18% is written across borders.

How has Oncomatryx (Spain)'s research output changed?

Output in 2022-2025 was 74% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Derio

All research institutions in Derio

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Oncomatryx (Spain). Posts are plain text and can be reported.